Treating malaria in Africa

British Medical Journal

Volumn 328, Issue 7439, 2004, Pages 534-535

  Greenwood, Brian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; QUININE;

AFRICA; DRUG EFFICACY; EDITORIAL; GENETIC ANALYSIS; MALARIA; MALARIA CONTROL; MEDICAL RESEARCH; MORTALITY; PLASMODIUM; PRIORITY JOURNAL;

EID: 1542373543     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7439.534     Document Type: Editorial

References (11)

1. Trape J-F, Pison G, Preziosi M-P, Enel C, Desgrées du Loû A, Delaunay V, et al. Impact of chloroquine resistance on malaria mortality. C R Acad Sci Paris 1998;321:689-97.
2. Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress towards targets based on verbal autopsy. Lancet Infect Dis 2003;3:349-58.
3. Fogh S, Jepsen S, Efferson P. Chloroquine-resistant Plasmodium falciparum in Kenya. Trans R Soc Trop Med Hyg 1979;73228-9.
4. Kean BH. Chloroquine-resistant falciparum malaria from Africa. JAMA 1979;241:395.
5. East Africa Network for Monitoring Antimalarial Treatment (EANMAT). Monitoring antimalarial drug resistance within national malaria control programmes: the EANMAT experience. Trop Med Int Health 2001;6:891-8.
6. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002;2:209-18.
7. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, et al. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 2001;358:1218-23.
8. East African Network for Monitoring Antimalarial Treatment (EANMAT). The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health 2003;8:860-7.
9. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 2003;361:1174-81.
10. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RAG, Chimpeni P, et al. Sustained efficacy sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prpspective study. BMJ 2004;328:545-8.
11. Nosten F, Brasseur P. Combination therapy for malaria. The way forward. Drugs 2002;62:1315-29.